​

McKesson (MCK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MCK Stock Forecast

McKesson (MCK) stock forecast, based on 31 Wall Street analysts, predicts a 12-month average price target of $983.13, with a high of $1,200.00 and a low of $845.00. This represents a -2.89% decline from the last price of $1,012.34.

$700 $800 $900 $1 $1 $1 High: $1200 Avg: $983.13 Low: $845 Last Closed Price: $1012.34

MCK Stock Rating

McKesson stock's rating consensus is Buy, based on 31 Wall Street analysts. The breakdown includes 1 Strong Buy (3.23%), 24 Buy (77.42%), 6 Hold (19.35%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 31 6 24 1 Strong Sell Sell Hold Buy Strong Buy

MCK Price Target Upside V Benchmarks

TypeNameUpside
StockMcKesson-2.89%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks5.55%

Price Target Trends

1M3M12M
# Anlaysts3717
Avg Price Target$1.07K$998.57$990.24
Last Closing Price$1.01K$1.01K$1.01K
Upside/Downside5.27%-1.36%-2.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 263104--17
Sep, 263114--18
Aug, 263113--17
Jul, 264112--17
Jun, 264112--17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 20, 2026Mizuho Securities$1.02K$1.01K0.95%0.76%
Oct 16, 2026UBS$1.20K$998.6420.16%18.54%
Oct 06, 2026Erin WrightMorgan Stanley$977.00$915.456.72%-3.49%
Aug 19, 2026Glen SantangeloBarclays$1.00K$869.2615.04%-1.22%
Aug 19, 2026Ryan HalstedRBC Capital$845.00$869.26-2.79%-16.53%
Aug 11, 2026Stephan BaxterWells Fargo$933.00$879.876.04%-7.84%
Aug 06, 2026Robert W. Baird$1.01K$843.8920.28%0.26%
May 08, 2026Kevin CaliendoUBS$1.05K$744.4641.04%3.72%
May 08, 2026George HillDeutsche Bank$875.00$763.9014.54%-13.57%
Mar 05, 2026Raymond James$970.00$930.314.27%-4.18%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 16, 2026UBSBuyBuyhold
Aug 19, 2026BarclaysOverweightOverweighthold
Aug 19, 2026RBC CapitalSector Performinitialise
Aug 07, 2026Morgan StanleyOverweightOverweighthold
Aug 06, 2026Evercore ISIOutperformOutperformhold
Aug 06, 2026Cowen & Co.BuyBuyhold
Aug 06, 2026UBSBuyBuyhold
Jul 24, 2026CitigroupBuyBuyhold
May 08, 2026UBSBuyBuyhold
May 08, 2026Deutsche BankBuyBuyhold

Financial Forecast

EPS Forecast

$5 $16 $27 $38 $49 $60 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$7.31$25.23$22.54$25.86$38.55---
Avg Forecast$23.89$25.96$27.61$32.69$36.82$41.28$46.94$53.78
High Forecast$24.51$26.88$27.95$32.97$37.67$43.85$48.61$55.70
Low Forecast$23.20$25.16$27.47$32.40$35.56$35.30$45.51$52.14
Surprise %-69.40%-2.81%-18.36%-20.89%4.70%---

Revenue Forecast

$250B $310B $370B $430B $490B $550B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$263.97B$276.71B$308.95B$359.05B$403.43B---
Avg Forecast$260.88B$275.91B$311.92B$360.18B$396.03B$424.30B$464.80B$517.85B
High Forecast$266.13B$283.48B$312.88B$362.60B$412.08B$425.21B$477.55B$532.05B
Low Forecast$255.12B$269.43B$309.58B$357.80B$382.12B$423.39B$453.88B$505.68B
Surprise %1.18%0.29%-0.95%-0.31%1.87%---

Net Income Forecast

$500M $2B $3B $5B $6B $8B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$1.11B$3.56B$3.00B$3.29B$4.76B---
Avg Forecast$1.15B$3.48B$3.00B$4.38B$4.91B$5.31B$6.29B$7.21B
High Forecast$1.39B$3.60B$3.60B$4.42B$5.05B$5.88B$6.52B$7.47B
Low Forecast$919.44M$3.37B$2.39B$4.34B$4.77B$4.73B$6.10B$6.99B
Surprise %-3.33%2.28%0.13%-24.81%-3.00%---

MCK Forecast FAQ

Is McKesson stock a buy?

McKesson stock has a consensus rating of Buy, based on 31 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 24 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that McKesson is a favorable investment for most analysts.

What is McKesson's price target?

McKesson's price target, set by 31 Wall Street analysts, averages $983.13 over the next 12 months. The price target range spans from $845 at the low end to $1.2K at the high end, suggesting a potential -2.89% change from the previous closing price of $1.01K.

How does McKesson stock forecast compare to its benchmarks?

McKesson's stock forecast shows a -2.89% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical distribution stocks industry (5.55%).

What is the breakdown of analyst ratings for McKesson over the past three months?

  • October 2026: 17.65% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 16.67% Strong Buy, 61.11% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 17.65% Strong Buy, 64.71% Buy, 17.65% Hold, 0% Sell, 0% Strong Sell.

What is McKesson’s EPS forecast?

McKesson's average annual EPS forecast for its fiscal year ending in March 2027 is $41.28, marking a 7.08% increase from the reported $38.55 in 2026. Estimates for the following years are $46.94 in 2028, and $53.78 in 2029.

What is McKesson’s revenue forecast?

McKesson's average annual revenue forecast for its fiscal year ending in March 2027 is $424.3B, reflecting a 5.17% increase from the reported $403.43B in 2026. The forecast for 2028 is $464.8B, and $517.85B for 2029.

What is McKesson’s net income forecast?

McKesson's net income forecast for the fiscal year ending in March 2027 stands at $5.31B, representing an 11.45% increase from the reported $4.76B in 2026. Projections indicate $6.29B in 2028, and $7.21B in 2029.